Loading…
Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Saved in:
| Published in: | Antimicrobial Agents and Chemotherapy 2007-10, Vol.51 (10), p.3612-3616 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203 |
|---|---|
| cites | cdi_FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203 |
| container_end_page | 3616 |
| container_issue | 10 |
| container_start_page | 3612 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 51 |
| creator | Talbot, George H Thye, Dirk Das, Anita Ge, Yigong |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.00590-07 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1128_AAC_00590_07</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19977079</sourcerecordid><originalsourceid>FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203</originalsourceid><addsrcrecordid>eNp1kd1rFDEUxQdR7Lb65rMMgoLg1GSSSSYvwrL4USgo7Poc7mRuOqnzsU0ylf3vm3YWqw8-JeH8ck5yT5a9ouSc0rL-uF5vzgmpFCmIfJKtKFF1ISolnmYrQoQoeE34SXYawjVJ58Q9z06oFHVJFF9l4UcHAfMy38a5PeSTzTdoI_ipdyPmt-jDHJIGYwu-zXcdetgfcjfmO48QBxzjw51p2PfOQMQ23_5KauKXzTb62cTZY34xWjTRTWN4kT2z0Ad8eVzPsp9fPu8234rL718vNuvLArhksVANb8DUjeCqASprBmAkIjaVtZJywWslJDeNwKqi0DJDy0o2trStEYKUhJ1lnxbf_dwM2Jr0WA-93ns3gD_oCZz-Vxldp6-mW10SzkpRJ4N3RwM_3cwYoh5cMNj3MOI0B02VkpJIlcAPC2j8FIJH-yeEEn3fkk4t6YeWNJEJf7_gEIZSX0-zH9Mc_se-_vsTj8bHChPw9ghAMNBbD6Nx4ZFTlDLJWOLeLFznrrrfzqNO6TrNVFf0PpoJWrI7IZ-0Eg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19977079</pqid></control><display><type>article</type><title>Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections</title><source>American Society for Microbiology Journals</source><source>PubMed Central</source><creator>Talbot, George H ; Thye, Dirk ; Das, Anita ; Ge, Yigong</creator><creatorcontrib>Talbot, George H ; Thye, Dirk ; Das, Anita ; Ge, Yigong</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00590-07</identifier><identifier>PMID: 17682094</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adult ; Anti-Bacterial Agents ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Aztreonam - therapeutic use ; Biological and medical sciences ; Ceftaroline ; Cephalosporins ; Cephalosporins - adverse effects ; Cephalosporins - therapeutic use ; Clinical Therapeutics ; Female ; Humans ; Male ; Medical sciences ; Methicillin Resistance ; Middle Aged ; Pharmacology. Drug treatments ; Recurrence ; Skin Diseases, Infectious ; Skin Diseases, Infectious - drug therapy ; Skin Diseases, Infectious - microbiology ; Staphylococcus aureus ; Streptococcus agalactiae - drug effects ; Treatment Outcome ; Vancomycin - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3612-3616</ispartof><rights>2007 INIST-CNRS</rights><rights>Copyright © 2007 American Society for Microbiology</rights><rights>Copyright © 2007, American Society for Microbiology 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203</citedby><cites>FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/AAC.00590-07$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/AAC.00590-07$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,3189,27924,27925,52751,52752,52753,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19113733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17682094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talbot, George H</creatorcontrib><creatorcontrib>Thye, Dirk</creatorcontrib><creatorcontrib>Das, Anita</creatorcontrib><creatorcontrib>Ge, Yigong</creatorcontrib><title>Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adult</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Aztreonam - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Ceftaroline</subject><subject>Cephalosporins</subject><subject>Cephalosporins - adverse effects</subject><subject>Cephalosporins - therapeutic use</subject><subject>Clinical Therapeutics</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Recurrence</subject><subject>Skin Diseases, Infectious</subject><subject>Skin Diseases, Infectious - drug therapy</subject><subject>Skin Diseases, Infectious - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Streptococcus agalactiae - drug effects</subject><subject>Treatment Outcome</subject><subject>Vancomycin - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp1kd1rFDEUxQdR7Lb65rMMgoLg1GSSSSYvwrL4USgo7Poc7mRuOqnzsU0ylf3vm3YWqw8-JeH8ck5yT5a9ouSc0rL-uF5vzgmpFCmIfJKtKFF1ISolnmYrQoQoeE34SXYawjVJ58Q9z06oFHVJFF9l4UcHAfMy38a5PeSTzTdoI_ipdyPmt-jDHJIGYwu-zXcdetgfcjfmO48QBxzjw51p2PfOQMQ23_5KauKXzTb62cTZY34xWjTRTWN4kT2z0Ad8eVzPsp9fPu8234rL718vNuvLArhksVANb8DUjeCqASprBmAkIjaVtZJywWslJDeNwKqi0DJDy0o2trStEYKUhJ1lnxbf_dwM2Jr0WA-93ns3gD_oCZz-Vxldp6-mW10SzkpRJ4N3RwM_3cwYoh5cMNj3MOI0B02VkpJIlcAPC2j8FIJH-yeEEn3fkk4t6YeWNJEJf7_gEIZSX0-zH9Mc_se-_vsTj8bHChPw9ghAMNBbD6Nx4ZFTlDLJWOLeLFznrrrfzqNO6TrNVFf0PpoJWrI7IZ-0Eg</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Talbot, George H</creator><creator>Thye, Dirk</creator><creator>Das, Anita</creator><creator>Ge, Yigong</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20071001</creationdate><title>Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections</title><author>Talbot, George H ; Thye, Dirk ; Das, Anita ; Ge, Yigong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Aztreonam - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Ceftaroline</topic><topic>Cephalosporins</topic><topic>Cephalosporins - adverse effects</topic><topic>Cephalosporins - therapeutic use</topic><topic>Clinical Therapeutics</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Recurrence</topic><topic>Skin Diseases, Infectious</topic><topic>Skin Diseases, Infectious - drug therapy</topic><topic>Skin Diseases, Infectious - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Streptococcus agalactiae - drug effects</topic><topic>Treatment Outcome</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talbot, George H</creatorcontrib><creatorcontrib>Thye, Dirk</creatorcontrib><creatorcontrib>Das, Anita</creatorcontrib><creatorcontrib>Ge, Yigong</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talbot, George H</au><au>Thye, Dirk</au><au>Das, Anita</au><au>Ge, Yigong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>51</volume><issue>10</issue><spage>3612</spage><epage>3616</epage><pages>3612-3616</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>17682094</pmid><doi>10.1128/AAC.00590-07</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3612-3616 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_crossref_primary_10_1128_AAC_00590_07 |
| source | American Society for Microbiology Journals; PubMed Central |
| subjects | Adult Anti-Bacterial Agents Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Aztreonam - therapeutic use Biological and medical sciences Ceftaroline Cephalosporins Cephalosporins - adverse effects Cephalosporins - therapeutic use Clinical Therapeutics Female Humans Male Medical sciences Methicillin Resistance Middle Aged Pharmacology. Drug treatments Recurrence Skin Diseases, Infectious Skin Diseases, Infectious - drug therapy Skin Diseases, Infectious - microbiology Staphylococcus aureus Streptococcus agalactiae - drug effects Treatment Outcome Vancomycin - therapeutic use |
| title | Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A04%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%202%20Study%20of%20Ceftaroline%20versus%20Standard%20Therapy%20in%20Treatment%20of%20Complicated%20Skin%20and%20Skin%20Structure%20Infections&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Talbot,%20George%20H&rft.date=2007-10-01&rft.volume=51&rft.issue=10&rft.spage=3612&rft.epage=3616&rft.pages=3612-3616&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.00590-07&rft_dat=%3Cproquest_cross%3E19977079%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a473t-9b4bac8b649ba1783aac7eeeb5ff7146489674cb6e551ad3c1257bf2fdc660203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19977079&rft_id=info:pmid/17682094&rfr_iscdi=true |